Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab
Clinical trial NCT03412630 · TERMINATED
Trial details
- NCT number
- NCT03412630
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2019-03-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.